263 related articles for article (PubMed ID: 19022265)
1. Genetic variation in normal tissue toxicity induced by ionizing radiation.
Popanda O; Marquardt JU; Chang-Claude J; Schmezer P
Mutat Res; 2009 Jul; 667(1-2):58-69. PubMed ID: 19022265
[TBL] [Abstract][Full Text] [Related]
2. Genetic markers for prediction of normal tissue toxicity after radiotherapy.
Alsner J; Andreassen CN; Overgaard J
Semin Radiat Oncol; 2008 Apr; 18(2):126-35. PubMed ID: 18314067
[TBL] [Abstract][Full Text] [Related]
3. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
[TBL] [Abstract][Full Text] [Related]
4. [Individual response to ionising radiation: What predictive assay(s) to choose?].
Granzotto A; Joubert A; Viau M; Devic C; Maalouf M; Thomas C; Vogin G; Malek K; Colin C; Balosso J; Foray N
C R Biol; 2011 Feb; 334(2):140-57. PubMed ID: 21333944
[TBL] [Abstract][Full Text] [Related]
5. Finding the genetic determinants of adverse reactions to radiotherapy.
Rattay T; Talbot CJ
Clin Oncol (R Coll Radiol); 2014 May; 26(5):301-8. PubMed ID: 24702740
[TBL] [Abstract][Full Text] [Related]
6. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients.
Pugh TJ; Keyes M; Barclay L; Delaney A; Krzywinski M; Thomas D; Novik K; Yang C; Agranovich A; McKenzie M; Morris WJ; Olive PL; Marra MA; Moore RA
Clin Cancer Res; 2009 Aug; 15(15):5008-16. PubMed ID: 19638463
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphisms of DNA repair genes as predictors of radioresponse.
Parliament MB; Murray D
Semin Radiat Oncol; 2010 Oct; 20(4):232-40. PubMed ID: 20832015
[TBL] [Abstract][Full Text] [Related]
8. Predictive markers for normal tissue reactions: fantasy or reality?
Fernet M; Hall J
Cancer Radiother; 2008 Nov; 12(6-7):614-8. PubMed ID: 18752979
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte telomere length correlates with in vitro radiosensitivity in breast cancer cases but is not predictive of acute normal tissue reactions to radiotherapy.
Iwasaki T; Robertson N; Tsigani T; Finnon P; Scott D; Levine E; Badie C; Bouffler S
Int J Radiat Biol; 2008 Apr; 84(4):277-84. PubMed ID: 18386193
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
[TBL] [Abstract][Full Text] [Related]
11. Genetic biomarkers of therapeutic radiation sensitivity.
Fernet M; Hall J
DNA Repair (Amst); 2004; 3(8-9):1237-43. PubMed ID: 15279812
[TBL] [Abstract][Full Text] [Related]
12. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.
Ho AY; Atencio DP; Peters S; Stock RG; Formenti SC; Cesaretti JA; Green S; Haffty B; Drumea K; Leitzin L; Kuten A; Azria D; Ozsahin M; Overgaard J; Andreassen CN; Trop CS; Park J; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):646-55. PubMed ID: 16751059
[TBL] [Abstract][Full Text] [Related]
13. Correlation between DNA repair capacity in lymphocytes and acute side effects to skin during radiotherapy in nasopharyngeal cancer patients.
Wang WD; Chen ZT; Li DZ; Cao ZH; Sun SL; Pu P; Chen XP
Clin Cancer Res; 2005 Jul; 11(14):5140-5. PubMed ID: 16033828
[TBL] [Abstract][Full Text] [Related]
14. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?
Andreassen CN
Acta Oncol; 2005; 44(8):801-15. PubMed ID: 16332587
[TBL] [Abstract][Full Text] [Related]
15. Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: A pilot study in prostate cancer patients receiving radiotherapy.
Hümmerich J; Werle-Schneider G; Popanda O; Celebi O; Chang-Claude J; Kropp S; Mayer C; Debus J; Bartsch H; Schmezer P
Int J Radiat Biol; 2006 Aug; 82(8):593-604. PubMed ID: 16966187
[TBL] [Abstract][Full Text] [Related]
16. Identifying patients at risk for late radiation-induced toxicity.
Azria D; Betz M; Bourgier C; Jeanneret Sozzi W; Ozsahin M
Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e35-41. PubMed ID: 20869261
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of radiation exposure: can they predict normal tissue radiosensitivity?
Chua ML; Rothkamm K
Clin Oncol (R Coll Radiol); 2013 Oct; 25(10):610-6. PubMed ID: 23870757
[TBL] [Abstract][Full Text] [Related]
18. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
[TBL] [Abstract][Full Text] [Related]
19. Increased radiosensitivity as an indicator of genes conferring breast cancer susceptibility.
Varga D; Vogel W; Bender A; Surowy H; Maier C; Kreienberg R; Deissler H; Sauer G
Strahlenther Onkol; 2007 Dec; 183(12):655-60. PubMed ID: 18040608
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility to radiations. Which impact on medical practice?
Alapetite C; Cosset JM; Bourguignon MH; Masse R
Q J Nucl Med; 2000 Dec; 44(4):347-54. PubMed ID: 11302263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
